Meihua International Medical Technologies Co., Ltd.(MHUA)Earnings, Financials & Key Ratios
MHUA•NASDAQ
$7.61
0.2× P/E·Price updated Jun 20, 2026
AboutMeihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.Show more
- Revenue$97M-0.2%
- EBITDA$15M-1.7%
- Net Income$11M-6.7%
- EPS (Diluted)40.00-18.4%
- Gross Margin34.36%+0.8%
- EBITDA Margin15.36%-1.5%
- Operating Margin14.77%-2.3%
- Net Margin11.19%-6.5%
- ROE7.09%-12.9%
MHUA Price & Volume
Meihua International Medical Technologies Co., Ltd. (MHUA) stock price & volume — 10-year historical chart
Loading chart...
Margin Compression and Cash Flow Volatility Risks
Investment Thesis • Updated 2025Q2
VerdictNegative
Growth:Contracting
Profitability:Strained
Financial:Healthy
Cash Flow:Deteriorating
Primary Risk:Volume-Based Procurement Price Erosion
Key Thesis Takeaways
- Meihua International faces significant headwinds as revenue contracted 16.2% YoY in 2025Q2, exacerbated by structural margin compression to 33.2% due to centralized procurement pressures.
- While the company maintains a conservative debt-to-equity ratio of 0.07, the severe disconnect between accounting profits and cash generation, evidenced by a -6.30 operating cash flow to net income ratio, raises concerns regarding earnings quality.
- Investors should monitor the company's ability to stabilize its cash conversion cycle, as the current reliance on non-cash assets may limit future reinvestment capacity.
Verdict Logic
the company's inability to convert net income into cash, highlighted by a -6.30 OCF/NI ratio in 2025Q2, suggests significant liquidity risks that outweigh the current low valuation multiples.
MHUA Growth Metrics
Meihua International Medical Technologies Co., Ltd. (MHUA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years4.01%
3 Years-2.34%
TTM-11.3%
Profit CAGR
10 Years-
5 Years-6.81%
3 Years-19.71%
TTM-26.27%
EPS CAGR
10 Years-
5 Years-8.97%
3 Years-23.4%
TTM-44.54%
Return on Capital
10 Years24.07%
5 Years17.63%
3 Years9.45%
Last Year9.36%
Peers Comparison
Key metrics vs top competitors for Meihua International Medical Technologies Co., Ltd. (MHUA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $7.61 | $2.08M | 0.19 | -0.19% | 11.19% | 7.09% | — | |
| $9.30 | $104.91M | 25.14 | 30.75% | 17.66% | 8.33% | — | |
| $9.38 | $1.42B | -9.77 | 24.95% | -21.07% | -443.09% | — | |
| $2.98 | $327.88K | -0.31 | — | -227.72% | -25.53% | — | |
| $72.14 | $4.3B | 33.87 | 11.66% | 9.03% | 8.95% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — |
Compare MHUA vs Peers
Meihua International Medical Technologies Co., Ltd. (MHUA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when MHUA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MHUA Frequently Asked Questions
Meihua International Medical Technologies Co., Ltd. (MHUA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Meihua International Medical Technologies Co., Ltd.'s revenue?
Meihua International Medical Technologies Co., Ltd. (MHUA) reported $183.8M in revenue for fiscal year 2024. This represents a 143% increase from $75.7M in 2018.
How fast is Meihua International Medical Technologies Co., Ltd. growing?
Meihua International Medical Technologies Co., Ltd. (MHUA) saw revenue decline by 0.2% over the past year.
Is MHUA profitable?
Yes, Meihua International Medical Technologies Co., Ltd. (MHUA) is profitable, generating $18.6M in net income for fiscal year 2024 (11.2% net margin).
Dividend & Returns
What is MHUA's return on equity?
Meihua International Medical Technologies Co., Ltd. (MHUA) has a return on equity (ROE) of 7.1%. This is below average, suggesting room for improvement.
What is Meihua International Medical Technologies Co., Ltd.'s free cash flow?
Meihua International Medical Technologies Co., Ltd. (MHUA) generated $12.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.